[HTML][HTML] Long COVID: pathophysiological factors and abnormalities of coagulation

S Turner, MA Khan, D Putrino, A Woodcock… - Trends in Endocrinology …, 2023 - cell.com
Acute COVID-19 infection is followed by prolonged symptoms in approximately one in ten
cases: known as Long COVID. The disease affects~ 65 million individuals worldwide. Many …

SARS-CoV-2: structure, biology, and structure-based therapeutics development

MY Wang, R Zhao, LJ Gao, XF Gao… - Frontiers in cellular …, 2020 - frontiersin.org
The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has been posing great threats to the world in many aspects. Effective therapeutic and …

Deep learning and medical image processing for coronavirus (COVID-19) pandemic: A survey

S Bhattacharya, PKR Maddikunta, QV Pham… - Sustainable cities and …, 2021 - Elsevier
Since December 2019, the coronavirus disease (COVID-19) outbreak has caused many
death cases and affected all sectors of human life. With gradual progression of time, COVID …

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

L Wang, Y Wang, D Ye, Q Liu - International journal of antimicrobial agents, 2020 - Elsevier
COVID-19, the disease caused by SARS-CoV-2, is a highly contagious disease. The World
Health Organization has declared the ongoing outbreak to be a global public health …

The epidemiology and clinical information about COVID-19

H Ge, X Wang, X Yuan, G Xiao, C Wang… - European journal of …, 2020 - Springer
In December 2019, pneumonia of unknown cause occurred in Wuhan, Hubei Province,
China. On 7 January 2020, a novel coronavirus, named as severe acute respiratory …

[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions

AI Abulsoud, HM El-Husseiny, AA El-Husseiny… - Biomedicine & …, 2023 - Elsevier
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status

TM Abd El-Aziz, JD Stockand - Infection, Genetics and evolution, 2020 - Elsevier
Coronaviruses are a large group of viruses known to cause illnesses that vary between the
common cold and more severe diseases to include severe acute respiratory syndrome …

SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights

SB Kadam, GS Sukhramani, P Bishnoi… - Journal of basic …, 2021 - Wiley Online Library
The outbreak of a novel coronavirus associated with acute respiratory disease, called
COVID‐19, marked the introduction of the third spillover of an animal coronavirus (CoV) to …

SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19)

A Ruiz-Bravo, M Jiménez-Valera - Ars Pharmaceutica (Internet), 2020 - SciELO Espana
Método: Se examinaron las publicaciones más relevantes en relación con los objetivos de
la revisión. Resultados: La enfermedad, conocida como COVID-19, cursa con tos, fiebre y …

SARS-CoV-2 spike protein S1 induces fibrin (ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19

LM Grobbelaar, C Venter, M Vlok, M Ngoepe… - Bioscience …, 2021 - portlandpress.com
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced infection, the
cause of coronavirus disease 2019 (COVID-19), is characterized by unprecedented clinical …